203 related articles for article (PubMed ID: 27519650)
21. Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.
Sawant KP; Fule R; Maniruzzaman M; Amin PD
Drug Deliv Transl Res; 2018 Dec; 8(6):1679-1693. PubMed ID: 29948916
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Biopharmaceutical Performance of Rivaroxaban through Polymeric Amorphous Solid Dispersion.
Metre S; Mukesh S; Samal SK; Chand M; Sangamwar AT
Mol Pharm; 2018 Feb; 15(2):652-668. PubMed ID: 29287144
[TBL] [Abstract][Full Text] [Related]
23. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
24. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
25. Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films.
Prodduturi S; Manek RV; Kolling WM; Stodghill SP; Repka MA
J Pharm Sci; 2005 Oct; 94(10):2232-45. PubMed ID: 16136579
[TBL] [Abstract][Full Text] [Related]
26. Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations.
Han R; Huang T; Liu X; Yin X; Li H; Lu J; Ji Y; Sun H; Ouyang D
AAPS PharmSciTech; 2019 Aug; 20(7):274. PubMed ID: 31385095
[TBL] [Abstract][Full Text] [Related]
27. Hot-melt extrusion process impact on polymer choice of glyburide solid dispersions: The effect of wettability and dissolution.
Alshafiee M; Aljammal MK; Markl D; Ward A; Walton K; Blunt L; Korde S; Pagire SK; Kelly AL; Paradkar A; Conway BR; Asare-Addo K
Int J Pharm; 2019 Mar; 559():245-254. PubMed ID: 30699365
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends.
Prodduturi S; Urman KL; Otaigbe JU; Repka MA
AAPS PharmSciTech; 2007 Jun; 8(2):Article 50. PubMed ID: 17622123
[TBL] [Abstract][Full Text] [Related]
29. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
[TBL] [Abstract][Full Text] [Related]
30. Effect of carbamazepine on viscoelastic properties and hot melt extrudability of Soluplus ®.
Gupta SS; Parikh T; Meena AK; Mahajan N; Vitez I; Serajuddin ATM
Int J Pharm; 2015 Jan; 478(1):232-239. PubMed ID: 25448585
[TBL] [Abstract][Full Text] [Related]
31. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
32. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
[TBL] [Abstract][Full Text] [Related]
33. Characterization of poly(ethylene oxide) as a drug carrier in hot-melt extrusion.
Li L; AbuBaker O; Shao ZJ
Drug Dev Ind Pharm; 2006 Sep; 32(8):991-1002. PubMed ID: 16954112
[TBL] [Abstract][Full Text] [Related]
34. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
[TBL] [Abstract][Full Text] [Related]
35. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
36. The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platform.
Tian Y; Jacobs E; Jones DS; McCoy CP; Wu H; Andrews GP
Int J Pharm; 2020 Aug; 586():119545. PubMed ID: 32553496
[TBL] [Abstract][Full Text] [Related]
37. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
Li S; Tian Y; Jones DS; Andrews GP
AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
[TBL] [Abstract][Full Text] [Related]
38. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
[TBL] [Abstract][Full Text] [Related]
39. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
40. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
